Tonix Pharmaceuticals Holding Corp. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 27.98 million compared to USD 28.98 million a year ago. Basic loss per share from continuing operations was USD 58.56 compared to USD 135.68 a year ago.
For the nine months, net loss was USD 89.34 million compared to USD 78.54 million a year ago. Basic loss per share from continuing operations was USD 236.8 compared to USD 592 a year ago.